logo
Share SHARE
FONT-SIZE Plus   Neg

Metabolix Opens First European Office

Bioscience company Metabolix, Inc. (MBLX) said Wednesday that it has opened its new office in Cologne, Germany.

The new office marks the first expansion for Metabolix outside of the United States and will coordinate business development, customer service and technical support to business partners and biopolymer customers based in Europe.

Located in the BioCampus Cologne life science park, the space will enable the company to directly access the European market for biopolymers and will serve as a coordination point for its regional initiatives in renewable chemicals.

According to the Freedonia Group, global demand for bioplastics is expected to more than triple through 2015, with Western Europe remaining the largest consumer of bioplastic materials. With more than 700 issued and pending patents, Metabolix has led the industry in the development of a family of biopolymers called PHAs, or polyhydroxyalkanoates.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
British lender Lloyds Banking Group Plc. Friday reported higher profit in its first half, benefited by increased net interest income and margin as well as lower impairment. Looking ahead, the company lifted its net interest margin forecast. Amgen reported an increase in second-quarter profit, driven by sales of arthritis drug Enbrel and osteoporosis treatments Xgeva and Prolia, and improved margins. Both earnings and sales topped Wall Street estimates. Electronic Arts Inc. (EA) on Thursday reported an increase in profit for the first quarter, reflecting continued strong digital revenues, with both earnings and revenues topping Wall Street estimates. However, shares of the company fell over 4 percent, after having detailed a weak outlook. Redwood...
comments powered by Disqus
Follow RTT